Eloxx Shareholders Approve Reverse Split and Equity Changes

Eloxx Pharmaceuticals ( (ELOX) ) has issued an update.

On April 28, 2026, stockholders of Eloxx Pharmaceuticals holding 57.1% of the company’s outstanding common stock approved several corporate actions by written consent, including ratification of an amendment to the 2018 Equity Incentive Plan that raises the shares available for awards to 20 million and increases the incentive stock option limit to 30 million. They also approved a restated 2018 plan to extend the period for granting incentive stock options, expand the incentive stock option limit, prolong the evergreen feature and make administrative clarifications, along with amendments to the certificate of incorporation authorizing a potential reverse stock split at a ratio between 1-for-2 and 1-for-20 and reducing authorized common shares from 500 million to 100 million, all to be implemented at the board’s discretion after regulatory and notice requirements are met.

The company filed a preliminary information statement on April 28, 2026 and plans to mail a definitive statement before these measures take effect, signaling management’s intent to realign its equity structure and potentially bolster its share price while maintaining flexibility in equity compensation. For investors, the approved reverse split and large reduction in authorized shares could affect liquidity, capital-raising capacity and dilution dynamics once implemented, while the expanded equity plan underscores Eloxx’s continued reliance on stock-based incentives in its corporate strategy.

More about Eloxx Pharmaceuticals

Eloxx Pharmaceuticals, Inc. is a biopharmaceutical company that issues common stock to support its operations and uses an equity incentive plan to grant stock-based awards, including incentive stock options, to employees, directors and other participants. The company’s capital structure includes a large authorized share base, which it actively manages through shareholder-approved amendments to its charter and equity plans.

Average Trading Volume: 16,970

Technical Sentiment Signal: Sell

Current Market Cap: $594.1K

Find detailed analytics on ELOX stock on TipRanks’ Stock Analysis page.